Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
1.
Cytokine ; 166: 156205, 2023 06.
Article in English | MEDLINE | ID: mdl-37058963

ABSTRACT

Trichinella britovi is a widely distributed parasitic nematode, transmitted through ingestion of raw or poorly cooked meat containing muscle larvae. This helminth can regulate the host immune system during the early phase of infection. The immune mechanism mainly involves the interaction of Th1 and Th2 responses and related cytokines. Chemokines (C-X-C or C-C) and matrix metalloproteinases (MMPs) have also shown to be implicated in a number of parasitic infections, mainly malaria, neurocysticercosis, angiostronyloidosis, and schistosomiasis, but poor is known about their role in human Trichinella infection. We previously found that serum MMP-9 levels were significantly increased in T. britovi infected patients with relevant symptoms such as diarrhea, myalgia, and facial oedema, which makes these enzymes a potential reliable indicator of inflammation in trichinellosis patients. These changes were also observed in T. spiralis/T. pseudospiralis experimentally infected mice. No data are available about circulating levels of two pro-inflammatory chemokines, CXCL10 and CCL2, in trichinellosis patients with or w/o clinical signs of the infection. In this study, the association of serum level of CXCL10 and CCL2 with clinical outcome of T. britovi infection and their relation to MMP-9 were investigated. Patients (median age 49 ± 0.33 years) acquired infection by consuming raw sausages prepared with wild boar and pork meat. Sera were collected during the acute and the convalescent phases of the infection. A positive significant association (r = 0.61, p = 0.0004) was observed between MMP-9 and CXCL10 levels. The CXCL10 level significantly correlated with the severity of symptoms in patients being particularly higher in patients suffering diarrhea, myalgia, and facial oedema, thus suggesting a positive association of this chemokine with symptomatologic traits, especially myalgia (and increased LDH and CPK levels) (p < 0.005). No correlation was found between levels of CCL2 and the clinical symptoms.


Subject(s)
Parasites , Trichinellosis , Swine , Humans , Animals , Mice , Middle Aged , Trichinellosis/parasitology , Trichinellosis/veterinary , Matrix Metalloproteinase 9 , Myalgia , Neutrophils , Sus scrofa , Chemokines , Immunity , Edema , Chemokine CXCL10 , Chemokine CCL2
2.
Parasitology ; 150(12): 1077-1081, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37929593

ABSTRACT

Founded in 1959, the Italian Society of Parasitology (SoIPa) includes nearly 200 researchers and professionals in the fields of medicine, veterinary medicine, biotechnology, epidemiology and environmental sciences. The diversity of its members, in a historical and continuous collaboration with other international scientific societies, embodies a broad and multidisciplinary field such as parasitology. Since 1959, SoIPa has organized a biennial congress, covering all aspects of general parasitology with participants from all over Italy, Europe and beyond, involved in a dynamic and multi-faceted scientific framework of contributions and symposia. The present Special Issue (SI) contains 6 review papers and 1 research article, focussed on emerging topics presented and discussed during some of the symposia organized within the XXXII SoIPa Congress, held in Naples from 27th June to 30th June 2022. These review papers reflect several emerging subjects (i.e. 'Italian network on Neglected Tropical Diseases', 'Wildlife parasites and citizen science', 'Comparing approaches to parasitological issues', 'Unusual perspectives on the role of parasites') with the aim to explore the new role that parasitologists can play in the future society, working together to promote dialogue on science-informed decisions to support the so-called 'twin green and digital transition'.


Subject(s)
Parasites , Animals , Humans , Animals, Wild , Europe , Italy , Parasitology
3.
Parasitology ; 150(12): 1082-1088, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37264942

ABSTRACT

The World Health Organization (WHO) defines neglected tropical diseases (NTDs) as a diverse group of primarily infectious diseases, which disproportionately affect poor and marginalized populations worldwide. In this context, NTDs are responsible for important morbidity and mortality and justify a global response. Moreover, NTDs are relatively neglected by research and development as well as by funding, if compared with the magnitude of the public health problem they represent. This happens even though, unlike other infectious diseases, they can be prevented, controlled and eliminated by targeted public health interventions. NTDs are mainly prevalent in communities from low-income countries in tropical and sub-tropical areas but are also present in upper­middle-income countries, including several in Europe. Here, we provide an update on the most relevant parasitic endemic or imported NTDs in Italy and illustrate the rationale for the establishment of the Italian network on NTDs, an alliance of scientific societies, institutes, foundations, universities and non-profit organizations united to fight NTDs.


Subject(s)
Communicable Diseases , Parasites , Tropical Medicine , Animals , Humans , Neglected Diseases/epidemiology , Neglected Diseases/prevention & control , Italy/epidemiology , Global Health
4.
BMC Pediatr ; 23(1): 200, 2023 04 27.
Article in English | MEDLINE | ID: mdl-37101158

ABSTRACT

BACKGROUND: Intestinal parasitic infections are common in humans, especially among young children. These conditions are often asymptomatic and self-limiting, and diagnosis is mainly based on the search for ova and parasites in the stools since serology may be biased due to cross reactivity between parasites. Pinworm is common in children and is not usually associated with hypereosinophilia; adhesive-tape test is the gold standard testing for the microscopic detection of Enterobious vermicularis (Ev) eggs. CASE PRESENTATION: A 13-year-old boy was referred due to a self-resolving episode of vomiting and palpebral oedema after dinner, together with a history of chronic rhinitis, chronic cough, absolute IgA deficiency and Hashimoto's thyroiditis and hypereosinophilia (higher value = 3140/µl). On evaluation we detected only palpable thyroid and hypertrophic nasal turbinates. Food allergy was excluded, but skin prick tests showed sensitization to house dust mites and cat epithelium and spirometry showed a marked obstructive pattern with positive bronchodilation test prompting the diagnosis of asthma for which maintenance inhaled treatment was started. Chest x-ray and abdomen ultrasound were negative. Further blood testing showed positive IgG anti-Echinococcus spp. and Strongyloides stercoralis and positive IgE for Ascaris, while Ev were detected both by the adhesive tape test and stool examination, so that we made a final diagnosis of pinworm infection. Three months after adequate treatment with pyrantel pamoate the adhesive-tape test turned out negative and blood testing showed a normal eosinophil count. The child later developed also type 1 diabetes. CONCLUSIONS: We suggest the need to investigate for enterobiasis in children with hypereosinophilia and to consider autoimmunity as a potential confounding factor when interpreting serology for helminths.


Subject(s)
Asthma , Enterobiasis , Eosinophilia , Parasites , Male , Animals , Humans , Child , Child, Preschool , Adolescent , Enterobius , Enterobiasis/complications , Enterobiasis/diagnosis , Enterobiasis/drug therapy , Eosinophilia/etiology , Eosinophilia/complications , Asthma/complications
5.
Clin Exp Immunol ; 209(3): 305-310, 2022 09 29.
Article in English | MEDLINE | ID: mdl-35732270

ABSTRACT

Glutathione S-transferase omega-1 (GSTO1-1) is a cytosolic enzyme involved in the modulation of critical inflammatory pathways as well as in cancer progression. Auto-antibodies against GSTO1-1 were detected in the serum of patients with esophageal squamous cell carcinoma and were proposed as potential biomarkers in the early detection of the disease. Our findings show that anti-GSTO1-1 antibodies can be found in a variety of inflammatory diseases, including autoimmune rheumatoid arthritis, infectious SARS-CoV-2, and trichinellosis. Our findings strongly suggest that anti-GSTO1-1 antibodies may be a marker of tissue damage/inflammation rather than a specific tumor-associated biomarker.


Subject(s)
COVID-19 , Esophageal Neoplasms , Esophageal Squamous Cell Carcinoma , Biomarkers, Tumor , Glutathione Transferase , Humans , Inflammation , SARS-CoV-2
6.
Transfus Med ; 31(1): 63-68, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33295054

ABSTRACT

BACKGROUND: Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi and is transmitted by blood-sucking triatomine insects in endemic areas of Latin America. Transmission can also occur via blood transfusion and is a major cause of CD in non-endemic areas. OBJECTIVES: The aim of the study was to assess the prevalence of anti-T. cruzi antibodies in blood donors at risk of infection in Tuscany, Italy, following the introduction of blood safety Italian legislation. MATERIAL AND METHODS: Donors (N = 1985) were tested in 2016 to 2018 for anti-T. cruzi IgG using an immunochromatographic test (ICT). Chemiluminescent immunoassay (CLIA) was performed on ICT-positive donors to exclude CD, whereas enzyme-linked immunosorbent assay and western blot were performed in case of discordant results. All assays were performed on CD patients (N = 10) for validation. RESULTS: Ten blood donors had a positive ICT result, with a resulting T. cruzi seroprevalence of 0.5% but demonstrated negative results to CLIA, as well as to the other serological assays. The comparison of serological assays suggested a lower relative sensitivity of ICT. CONCLUSION: The results of this study confirm the significance of serological testing in the screening strategy for CD. However, they provide evidence for discontinuing the use of ICT as a screening test and suggest that a sensitive, specific and multi-sample format assay should be used at the national level for uniformity of results.


Subject(s)
Antibodies, Protozoan/blood , Blood Donors , Chagas Cardiomyopathy/blood , Donor Selection , Trypanosoma cruzi/metabolism , Adolescent , Adult , Aged , Chagas Cardiomyopathy/epidemiology , Chagas Cardiomyopathy/transmission , Female , Humans , Immunoassay , Italy/epidemiology , Male , Middle Aged , Risk Factors
7.
Exp Parasitol ; 225: 108112, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33964315

ABSTRACT

Matrix metalloproteinases (MMPs), are implicated in the pathogenesis of multiple sclerosis (MS) and in its animal model, experimental autoimmune encephalomyelitis (EAE). Our aim was to investigate whether amelioration of EAE in Dark Agouti (DA) rats, induced by Trichinella spiralis muscle larvae excretory-secretory products (ES L1), could be related to the level and activity of gelatinases, MMP-9 and MMP-2. Serum levels of MMP-9, MMP-2, NGAL/MMP-9, TIMP-1, and cytokines, evaluated by gel-zymography or ELISA, as well as gelatinases and TIMP-1 expression in the spinal cord (SC), were determined in: i) EAE induced, ii) ES L1-treated EAE induced animals. Milder clinical signs in ES L1-treated EAE induced DA rats were accompanied with lower serum levels of MMP-9 and NGAL/MMP-9 complex. However, the correlation between the severity of EAE and the level of serum MMP-9 was found only in the peak of the disease, with MMP-9/TIMP-1 ratio higher in EAE animals without ES L1 treatment. Lower expression of MMP-9 in SC of ES L1-treated, EAE induced rats, correlated with the reduced number of SC infiltrating cells. In SC infiltrates, in the effector and the recovery phase, production of anti-inflammatory cytokines IL-4 and IL-10 was higher in animals treated with ES L1 prior to EAE induction, compared to untreated EAE animals. Reduced expression of MMP-9 in SC tissue, which correlated with the reduced number of infiltrating cells, might be ascribed to regulatory mechanisms, among which is IL-10.


Subject(s)
Antigens, Helminth/therapeutic use , Encephalomyelitis, Autoimmune, Experimental/metabolism , Helminth Proteins/therapeutic use , Matrix Metalloproteinase 9/metabolism , Trichinella spiralis/metabolism , Animals , Cytokines/metabolism , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Encephalomyelitis, Autoimmune, Experimental/prevention & control , Inflammation , Interleukin-10/metabolism , Rats , Severity of Illness Index , Spinal Cord/immunology , Spinal Cord/metabolism , Spinal Cord/pathology , Tissue Inhibitor of Metalloproteinase-1/metabolism
8.
J Nerv Ment Dis ; 208(2): 118-126, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31985560

ABSTRACT

This study investigated the seroprevalence of Toxoplasma gondii in a cohort of 101 Italian inpatients affected by mood or schizophrenia-spectrum disorders and compared clinical features between seronegative and seropositive subjects. Patients diagnosed according to DSM-5 criteria underwent clinical assessments and blood collection to test parasite-specific IgG/IgM serum levels. Twenty-eight patients (27.7%) had IgG anti-T. gondii, and none had IgM antibodies. We found higher prevalence rate in patients aged 40 years or older, as compared with younger. No significant association was detected between T. gondii and a specific diagnostic category; however, bipolar disorder (BD)-II showed the highest positivity rate (40.9%). The seropositive status was significantly associated with a lower presence of psychotic symptoms, higher number of total episodes of predominant excitatory polarity, longer illness duration, and lower severity of current episode, particularly anxiety, depressive, and withdrawal/retardation symptoms. These preliminary results seem to point out an association between chronic toxoplasmosis and a specific subtype of BD.


Subject(s)
Bipolar Disorder/diagnosis , Schizophrenia/diagnosis , Schizophrenic Psychology , Toxoplasmosis/diagnosis , Toxoplasmosis/psychology , Adult , Aged , Bipolar Disorder/epidemiology , Bipolar Disorder/psychology , Chronic Disease , Cohort Studies , Comorbidity , Correlation of Data , Female , Humans , Italy , Male , Middle Aged , Schizophrenia/epidemiology , Seroepidemiologic Studies , Toxoplasmosis/epidemiology , Young Adult
9.
Malar J ; 18(1): 35, 2019 Feb 08.
Article in English | MEDLINE | ID: mdl-30736813

ABSTRACT

BACKGROUND: Medicinal plant research may contribute to develop new pharmacological control tools for vector borne diseases, such as malaria. METHODS: The effects of methanol extracts (ME) obtained from seed kernel of ripe and unripe Azadirachta indica fruits were studied on erythrocytic proliferation of the rodent malaria parasite Plasmodium berghei strain ANKA and on mice pro-inflammatory response, as evaluated by measuring the matrix-metalloproteinase-9 (MMP-9) and tumour necrosis factor (TNF) plasma levels, in two mouse strains (C57BL/6 and BALB/c) which are considered as prototypical of Th1 and Th2 immune response, respectively. RESULTS: ME obtained from seed kernel of unripe Azadirachta indica fruits decreased by about 30% the proportion of erythrocytes infected with the malaria parasite in C57BL/6 mice in the 4 days suppressive test. In this treatment group, MMP-9 and TNF levels were notably higher than those measured in the same mouse strain treated with the anti-malarial drug artesunate, Azadirachta indica kernel extracts from ripe fruits or solvent. In BALB/c mice, treatment with kernel extracts did not influence parasitaemia. MMP-9 and TNF levels measured in this mouse strain were notably lower than those recorded in C57BL/6 mice and did not vary among treatment groups. CONCLUSIONS: The effects of the ME on the parasite-host interactions appeared to be mouse strain-dependent, but also related to the ripening stage of the neem fruits, as only the unripe fruit seed kernel extracts displayed appreciable bioactivity.


Subject(s)
Antimalarials/pharmacology , Azadirachta/chemistry , Malaria/drug therapy , Parasitemia/drug therapy , Plant Extracts/pharmacology , Plasmodium berghei/drug effects , Animals , Drug Delivery Systems , Erythrocytes/parasitology , Female , Inflammation/drug therapy , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Plants, Medicinal/chemistry , Seeds/chemistry
10.
Malar J ; 18(1): 17, 2019 Jan 22.
Article in English | MEDLINE | ID: mdl-30670018

ABSTRACT

BACKGROUND: Transfusion with Plasmodium-infected blood represents a risk for malaria transmission, a rare but severe event. Several non-endemic countries implement a strategy for the screening of candidate blood donors including questionnaire for the identification of at-risk subjects and laboratory testing of blood samples, often serology-based, with temporary deferral from donation for individuals with a positive result. In Italy, the most recent legislation, issued in November 2015, introduced the use of serological tests for the detection of anti-Plasmodium antibodies. METHODS: In the absence of a gold standard for malaria serology, the aim of this work was to evaluate five commercial ELISA kits, and to determine their accuracy (sensitivity and specificity) in comparison to immuno-fluorescence antibody test (IFAT), and their agreement (concordance of results). Serum samples from malaria patients or from subjects with malaria history (N = 64), malaria naïve patients with other parasitic infections (N = 15), malaria naïve blood donors (N = 8) and malaria exposed candidate blood donors (N = 36) were tested. RESULTS: The specificity of all ELISA kits was 100%, while sensitivity ranged between 53 and 64% when compared to IFAT on malaria patients samples. When tested on candidate blood donors' samples, ELISA kits showed highly variable agreement (42-94%) raising the possibility that the same individual could be included or excluded from donation depending on the test in use by the transfusion centre. CONCLUSIONS: These preliminary results indicate how the lack of a gold standard for malaria serology must be taken into account in the application and future revision of current legislation. There is need of developing more sensitive serological assays. Moreover, the adoption of a unique serological test at national level is recommended, as well as the development of screening algorithms based on multiple laboratory tests, including molecular assays.


Subject(s)
Blood Donors/statistics & numerical data , Enzyme-Linked Immunosorbent Assay/methods , Malaria/diagnosis , Mass Screening/methods , Plasmodium/isolation & purification , Enzyme-Linked Immunosorbent Assay/instrumentation , Italy , Malaria/parasitology , Malaria/transmission , Mass Screening/instrumentation , Retrospective Studies , Sensitivity and Specificity
12.
Emerg Infect Dis ; 24(8): 1497-1504, 2018 08.
Article in English | MEDLINE | ID: mdl-30014843

ABSTRACT

Transplantation activity is increasing, leading to a growing number of patients at risk for toxoplasmosis. We reviewed toxoplasmosis prevention practices, prevalence, and outcomes for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT; heart, kidney, or liver) patients in Europe. We collected electronic data on the transplant population and prevention guidelines/regulations and clinical data on toxoplasmosis cases diagnosed during 2010-2014. Serologic pretransplant screening of allo-hematopoietic stem cell donors was performed in 80% of countries, screening of organ donors in 100%. SOT recipients were systematically screened in 6 countries. Targeted anti-Toxoplasma chemoprophylaxis was heterogeneous. A total of 87 toxoplasmosis cases were recorded (58 allo-HSCTs, 29 SOTs). The 6-month survival rate was lower among Toxoplasma-seropositive recipients and among allo-hematopoietic stem cell and liver recipients. Chemoprophylaxis improved outcomes for SOT recipients. Toxoplasmosis remains associated with high mortality rates among transplant recipients. Guidelines are urgently needed to standardize prophylactic regimens and optimize patient management.


Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Organ Transplantation/adverse effects , Toxoplasmosis/epidemiology , Toxoplasmosis/etiology , Adult , Europe/epidemiology , Humans , Middle Aged , Retrospective Studies , Risk Factors , Transplant Recipients
13.
Infection ; 51(5): 1249-1271, 2023 10.
Article in English | MEDLINE | ID: mdl-37420083
14.
Transpl Infect Dis ; 20(5): e12950, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29890019

ABSTRACT

We report a case of post-transplant liver graft infection with Schistosoma spp in a migrant from sub-Saharan Africa transplanted for HBV-related cirrhosis and with undiagnosed schistosomiasis pre-transplantation. The occurrence of tropical diseases in non-endemic areas warrants screening protocols for organ donors and recipients with a history of exposure in endemic areas.


Subject(s)
Liver Transplantation/adverse effects , Schistosoma haematobium/isolation & purification , Schistosomiasis haematobia/diagnosis , Adult , Africa South of the Sahara , Allografts/parasitology , Animals , Anthelmintics/therapeutic use , Humans , Liver/parasitology , Liver Cirrhosis/surgery , Male , Schistosomiasis haematobia/drug therapy , Schistosomiasis haematobia/parasitology , Transients and Migrants
15.
BMC Infect Dis ; 17(1): 530, 2017 08 01.
Article in English | MEDLINE | ID: mdl-28764637

ABSTRACT

BACKGROUND: Anisakiasis is a fish-borne zoonosis caused by Anisakis spp. larvae. One challenging issue in the diagnosis of anisakiasis is the molecular detection of the etiological agent even at very low quantity, such as in gastric or intestinal biopsy and granulomas. Aims of this study were: 1) to identify three new cases of invasive anisakiasis, by a species-specific Real-time PCR probe assay; 2) to detect immune response of the patients against the pathogen. METHODS: Parasite DNA was extracted from parasites removed in the three patients. The identification of larvae removed at gastric and intestinal level from two patients was first obtained by sequence analysis of mtDNA cox2 and EF1 α-1 of nDNA genes. This was not possible in the third patient, because of the very low DNA quantity obtained from a single one histological section of a surgically removed granuloma. Real-time PCR species-specific hydrolysis probe system, based on mtDNA cox2 gene, was performed on parasites tissue of the three cases. IgE, IgG4 and IgG immune response against antigens A. pegreffii by Immunoblotting assay was also studied. RESULTS: According to the mtDNA cox2 and the EF1 α - 1 nDNA sequence analysis, the larvae from stomach and intestine of two patients were assigned to A. pegreffii. The Real-time PCR primers/probe system, showed a fluorescent signal at 510 nm for A. pegreffii, in all the three cases. In Immunoblotting assay, patient CC1 showed IgE, IgG4 reactivity against Ani s 13-like and Ani s 7-like; patient CC2 revealed only IgG reactivity against Ani s 13-like and Ani s 7-like; while, the third patient showed IgE and IgG reactivity against Ani s 13-like, Ani s 7-like and Ani s 1-like. CONCLUSION: The Real-time PCR assay, a more sensitive method than direct DNA sequencing for the accurate and rapid identification of etiological agent of human anisakiasis, was successfully assessed for the first time. The study also highlights the importance to use both molecular and immunological tools in the diagnosis of human anisakiasis, in order to increase our knowledge about the pathological findings and immune response related to the infection by zoonotic species of the genus Anisakis.


Subject(s)
Anisakiasis/diagnosis , Anisakis/genetics , Immunoblotting/methods , Adult , Animals , Anisakiasis/etiology , Anisakiasis/immunology , Anisakis/immunology , Anisakis/pathogenicity , Cyclooxygenase 2/genetics , Female , Fishes/parasitology , Humans , Hydrolysis , Intestines/parasitology , Larva/genetics , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Species Specificity , Zoonoses
16.
Transpl Infect Dis ; 19(2)2017 Apr.
Article in English | MEDLINE | ID: mdl-28128496

ABSTRACT

BACKGROUND: Allogeneic hematopoietic stem cell transplant (HSCT) recipients are at substantial risk for a variety of infections depending upon numerous factors, such as degree of immunosuppression, host factors, and period after transplantation. Bacterial, fungal, viral, as well as parasitic infections can occur with high morbidity and mortality. OBJECTIVES: The aim of this study was to evaluate the magnitude of the occurrence of parasitic infections in allogeneic HSCT recipients. Modalities of transmission, methods of diagnosis, treatment, donor and recipient pre-transplant screening and prevention measures of the most serious parasitic infections have also been discussed. MATERIALS AND METHODS: We systematically reviewed literature records on post-transplant (allogeneic HSCT) parasitic infections, identified through PubMed database searching, using no language or time restrictions. Search was concluded on December 31, 2015. In the present review, we only discussed post-transplant parasitic infections in allogeneic HSCT. Only exclusion criteria were absence of sufficient information on the transmission of parasitic infection to the recipient. Autologous HSCT recipients have not been included because of the absence of a proper allogeneic transplantation even in presence of blood or blood product transfusions. The methods and findings of the present review have been reported based on the preferred reporting items for systematic reviews and meta-analysis checklist (PRISMA). RESULTS: Regarding allogeneic HSCT recipients, from data published in the literature the real burden of parasitic infections cannot be really estimated. Nevertheless, a positive trend on publication number exists, probably because of more than one reason: (i) the increasing number of patients transplanted and then treated with immunosuppressive agents, (ii) the "population shift" resulting from immigration and travels to endemic areas, and (iii) the increasing of attention for diagnosis/notification/publication of cases. CONCLUSIONS: Considering parasitic infections as emerging and potentially serious in their evolution, additional strategies for the prevention, careful screening and follow-up, with a high level of suspicion, identification, and preemptive therapy are necessary in transplant recipients. PERSPECTIVES: The Authors' viewpoint in the perspective to screen and follow-up active and latent chronic parasitosis in stem cells donors and recipients: a proposal for a flow chart.


Subject(s)
Communicable Diseases/epidemiology , Graft vs Host Disease/complications , Hematopoietic Stem Cell Transplantation/adverse effects , Immunosuppression Therapy/adverse effects , Immunosuppressive Agents/adverse effects , Parasitic Diseases/epidemiology , Chronic Disease , Communicable Diseases/complications , Communicable Diseases/diagnosis , Graft vs Host Disease/prevention & control , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Mass Screening/trends , Parasitic Diseases/complications , Parasitic Diseases/diagnosis , Transplant Recipients , Transplantation, Homologous/adverse effects
17.
J Nerv Ment Dis ; 205(3): 192-195, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27741079

ABSTRACT

Recent evidence suggests the involvement of Toxoplasma gondii infection in the emergence of psychotic and affective disorders. In this report, we describe the case of a young Brazilian woman affected by recurrent ocular toxoplasmosis and presenting with a manic episode with psychotic features in the context of a diagnosis of Bipolar Disorder (BD), type I. We observed a relationship between ocular manifestations and the clinical course of bipolar illness, confirmed by molecular analyses (nested-PCR), as well as by the high level of T. gondii specific IgG. This case report is the first showing the presence of circulating parasite DNA at the time of occurrence of psychiatric symptoms, thus providing further support for a possible role of the parasite in the pathogenesis of some cases of BD.


Subject(s)
Bipolar Disorder/physiopathology , Toxoplasmosis, Ocular/diagnosis , Adult , Bipolar Disorder/etiology , Bipolar Disorder/immunology , Bipolar Disorder/microbiology , Brazil , Female , Humans , Toxoplasmosis, Ocular/complications , Young Adult
18.
Food Microbiol ; 64: 65-71, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28213036

ABSTRACT

Trichinellosis is one of the most important foodborne zoonotic diseases, with worldwide distribution. While human risk for trichinellosis has historically been linked to pork, modern pork production systems and slaughter inspection programs have reduced or eliminated pork as a source for trichinellosis in many countries. While pork may no longer pose a significant risk for trichinellosis, many other animal species may be hosts for Trichinella species nematodes and when human consume meat from these animal species, there may be risk for acquiring trichinellosis. This review article describes the various non-pork meat sources of human trichinellosis outbreaks, where these outbreaks have occurred and some of the factors that contribute to human risk. The literature reviewed here provides evidence of the persistence of Trichinella as a human health risk for people who eat meat from feral and wild carnivores and scavengers, as well as some herbivores that have been shown to harbor Trichinella larvae. It points to the importance of education of hunters and consumers of these meats and meat products.


Subject(s)
Disease Outbreaks , Meat Products/parasitology , Meat/parasitology , Trichinellosis/transmission , Animals , Animals, Wild/parasitology , Deer/parasitology , Disease Outbreaks/prevention & control , Europe/epidemiology , Food Safety , Horses/microbiology , Humans , Sus scrofa/parasitology , Trichinella/isolation & purification , Trichinellosis/epidemiology , Trichinellosis/parasitology , Trichinellosis/prevention & control
19.
Clin Exp Rheumatol ; 32(4): 587-96, 2014.
Article in English | MEDLINE | ID: mdl-25065776

ABSTRACT

OBJECTIVES: Nowadays, several potent immunosuppressive drugs are available for patients with rheumatologic disorders. In general, these treatments are acceptably well tolerated. Nevertheless, in patients with rheumatic diseases, who are taking immunosuppressive drugs, an increased risk of bacterial, viral and fungal, as well as parasitic infections, exists. METHODS: We have reviewed literature, on PubMed library, on the topic 'parasitic infections in rheumatic disease patients treated with immunosuppressive drugs, including biological therapies'. We used no language or time restrictions. Search was concluded on January 15th 2014. We grouped all parasitic events among rheumatologic, therapeutically immuosuppressed, patients to estimate the magnitude of this risk. Then we gave our viewpoint in the perspective to screen and follow-up for active and latent chronic parasitoses, developing an hypothetical flow-chart. RESULTS: From data published in the literature the real burden of parasitoses, among patients with rheumatic diseases treated with immunosuppressive treatments, can not be estimated. Nevertheless, a positive trend on publication number exists, probably due to more than one reason: i) the increasing number of patients treated, especially with more than one immunosuppressive treatment, including new biological agents; ii) the increasing number of individuals who move from the north to the south of the world (endemic areas for parasitic infections) and vice versa, due to globalisation, and iii) the fact that more attention is paid for notification/publication of cases. CONCLUSIONS: Considering parasitic infections as emerging and potentially serious in their evolution, additional strategies for the prevention, careful screening and follow-up, with a high level of suspicion, identification, and pre-emptive therapy are necessary in candidate patients for biological agents.


Subject(s)
Immunocompromised Host , Immunosuppressive Agents/adverse effects , Opportunistic Infections/parasitology , Parasitic Diseases/parasitology , Rheumatic Diseases/drug therapy , Humans , Opportunistic Infections/diagnosis , Opportunistic Infections/immunology , Opportunistic Infections/prevention & control , Parasitic Diseases/diagnosis , Parasitic Diseases/immunology , Parasitic Diseases/prevention & control , Patient Selection , Prognosis , Rheumatic Diseases/diagnosis , Rheumatic Diseases/immunology , Risk Assessment , Risk Factors
20.
Emerg Infect Dis ; 19(3): 496-9, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23621984

ABSTRACT

Human cases of gastric anisakiasis caused by the zoonotic parasite Anisakis pegreffii are increasing in Italy. The disease is caused by ingestion of larval nematodes in lightly cooked or raw seafood. Because symptoms are vague and serodiagnosis is difficult, the disease is often misdiagnosed and cases are understimated.


Subject(s)
Anisakiasis/immunology , Anisakis/immunology , Stomach/parasitology , Animals , Anisakiasis/blood , Anisakiasis/parasitology , Anisakis/genetics , Antibodies, Helminth/blood , DNA, Ribosomal Spacer/genetics , Fish Diseases/parasitology , Fishes/parasitology , Genes, Helminth , Host-Parasite Interactions , Humans , Italy , Molecular Typing , Seafood/parasitology , Stomach/immunology , Zoonoses
SELECTION OF CITATIONS
SEARCH DETAIL